All
1.
Metabolic system alterations in pancreatic cancer patient serum: potential for early detection
Shawn A Ritchie, Hirofumi Akita, Ichiro Takemasa, Hidetoshi Eguchi, Elodie Pastural, Hiroaki Nagano, Morito Monden, Yuichiro Doki, Masaki Mori, Wei Jin, Tolulope T Sajobi, Dushmanthi Jayasinghe, Bassirou Chitou, Yasuyo Yamazaki, Thayer White, Dayan B Goodenowe BMC Cancer 2013, 13 :416 (12 September 2013)
Abstract | Full text | PDF
| ePUB | PubMed
2.
Analytic performance studies and clinical reproducibility of a real-time PCR
assay for the detection of epidermal growth factor receptor gene mutations in
formalin-fixed paraffin-embedded tissue specimens of non-small cell lung
cancer
Patrick O’Donnell, Jane Ferguson, Johnny Shyu, Robert Current, Taraneh Rehage, Julie Tsai, Mari Christensen, Ha Tran, Sean Shih-Chang Chien, Felice Shieh, Wen Wei, H Lawrence, Lin Wu, Robert Schilling, Kenneth Bloom, Warren Maltzman, Steven Anderson, Stephen Soviero BMC Cancer 2013, 13 :210 (27 April 2013)
Abstract | Full text | PDF
| ePUB | PubMed
3.
Exome profiling of primary, metastatic and recurrent ovarian carcinomas in a BRCA1 -positive patient
Jian Zhang, Yuhao Shi, Emilie Lalonde, Lili Li, Luca Cavallone, Alex Ferenczy, Walter H Gotlieb, William D Foulkes, Jacek Majewski BMC Cancer 2013, 13 :146 (22 March 2013)
Abstract | Full text | PDF
| ePUB | PubMed
|
Editor’s summary
Whole-exome sequencing of primary, metastatic and recurrent ovarian carcinoma from a single BRCA1-positive patient is a powerful method to detect subsequent somatic mutations and can provide information about the molecular evolution of BRCA1-driven ovarian cancer.
4.
Transposon activation mutagenesis as a screening tool for identifying resistance to cancer therapeutics
Li Chen, Lynda Stuart, Toshiro K Ohsumi, Shawn Burgess, Gaurav K Varshney, Anahita Dastur, Mark Borowsky, Cyril Benes, Adam Lacy-Hulbert, Emmett V Schmidt BMC Cancer 2013, 13 :93 (27 February 2013)
Abstract | Full text | PDF
| PubMed
5.
The significance and robustness of a plasma free amino acid (PFAA) profile-based multiplex function for detecting lung cancer
Masato Shingyoji, Toshihiko Iizasa, Masahiko Higashiyama, Fumio Imamura, Nobuhiro Saruki, Akira Imaizumi, Hiroshi Yamamoto, Takashi Daimon, Osamu Tochikubo, Toru Mitsushima, Minoru Yamakado, Hideki Kimura BMC Cancer 2013, 13 :77 (15 February 2013)
Abstract | Full text | PDF
| PubMed
6.
Does phosphorylation of cofilin affect the progression of human bladder cancer?
Hong Chung, Bokyung Kim, Seung-Hyo Jung, Kyung-Jong Won, Xiaowen Jiang, Chang-Kwon Lee, So Lim, Sang-Kuk Yang, Ki Song, Hong Kim BMC Cancer 2013, 13 :45 (1 February 2013)
Abstract | Full text | PDF
| PubMed
7.
Suppression subtractive hybridization identified differentially expressed genes in lung adenocarcinoma: ERGIC3 as a novel lung cancer-related gene
Mingsong Wu, Tao Tu, Yunchao Huang, Yi Cao BMC Cancer 2013, 13 :44 (1 February 2013)
Abstract | Full text | PDF
| PubMed
8.
Molecular pathways undergoing dramatic transcriptomic changes during tumor development in the human colon
Rosalia Maglietta, Vania Liuzzi, Elisa Cattaneo, Endre Laczko, Ada Piepoli, Anna Panza, Massimo Carella, Orazio Palumbo, Teresa Staiano, Federico Buffoli, Angelo Andriulli, Giancarlo Marra, Nicola Ancona BMC Cancer 2012, 12 :608 (19 December 2012)
Abstract | Full text | PDF
| PubMed
9.
Expression of aurora kinase A is associated with metastasis-free survival in node-negative breast cancer patients
Wulf Siggelkow, Daniel Boehm, Susanne Gebhard, Marco Battista, Isabel Sicking, Antje Lebrecht, Christine Solbach, Birte Hellwig, Jörg Rahnenführer, Heinz Koelbl, Mathias Gehrmann, Rosemarie Marchan, Cristina Cadenas, Jan G Hengstler, Marcus Schmidt BMC Cancer 2012, 12 :562 (27 November 2012)
Abstract | Full text | PDF
| PubMed
10.
Increased frequency of single base substitutions in a population of transcripts expressed in cancer cells
Laurent Bianchetti, David Kieffer, Rémi Féderkeil, Olivier Poch BMC Cancer 2012, 12 :509 (8 November 2012)
Abstract | Full text | PDF
| PubMed
